Fundació irsiCaixa-HIVACAT, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), Hospital Germans Trias, Universitat Autònoma de Barcelona, Spain.
AIDS. 2010 Apr 24;24(7):959-68. doi: 10.1097/QAD.0b013e328337b957.
The failure to increase CD4 T-cell counts in some HAART-treated HIV-infected patients with satisfactory virological responses has been related to low CD4 T-cell production, high turnover and death. However, the relative contribution of these factors is still unclear, strongly limiting the definition of appropriate therapeutic strategies for these patients.
A cross-sectional study was designed to evaluate the contribution of thymic activity, microbial translocation, cellular activation and death to CD4 T-cell recovery. We included 230 HIV-infected individuals on suppressive HAART (>2 years); 95 of them were considered 'discordant' (CD4 T-cell count <350 cells/mul) and 135 were considered 'concordant'. Comparative and logistic regression analyses were performed.
Discordant patients showed higher levels of activated [human leukocyte antigen (HLA)-DRCD95 and CD38CD45RA] cells in both the CD8 and CD4 T-cell compartments. Notably, the most significant differences were observed in CD4 T cells. Discordant patients showed lower naive CD4 T-cell production (CD45RACD31 cells), higher spontaneous ex-vivo CD4 T-cell death and higher plasma levels of soluble CD14. Multivariate analysis showed that activation and death of CD4 T cells, along with nadir CD4 T-cell counts, were the only predictive factors for poor immune recovery. Moreover, the low correlations found between CD4 T-cell activation or death with thymic output and bacterial translocation suggest that additional factors modulate cellular activation and death and, in turn, CD4 T-cell recovery.
CD4 T-cell repopulation during HAART is determined by CD4 T-cell activation and death. Therefore, strategies aimed to reduce these parameters should be envisaged to treat discordant patients.
在一些接受高效抗逆转录病毒治疗(HAART)且病毒学反应良好的 HIV 感染者中,CD4 T 细胞计数未能增加与 CD4 T 细胞产生减少、高周转率和死亡有关。然而,这些因素的相对贡献仍不清楚,这极大地限制了为这些患者制定适当治疗策略的定义。
设计了一项横断面研究,以评估胸腺活性、微生物易位、细胞激活和死亡对 CD4 T 细胞恢复的贡献。我们纳入了 230 名接受抑制性 HAART(>2 年)的 HIV 感染者;其中 95 名被认为是“不一致”(CD4 T 细胞计数<350 个/μl),135 名被认为是“一致”。进行了比较和逻辑回归分析。
不一致的患者在 CD8 和 CD4 T 细胞中均显示出更高水平的活化[人类白细胞抗原(HLA)-DRCD95 和 CD38CD45RA]细胞。值得注意的是,在 CD4 T 细胞中观察到最显著的差异。不一致的患者表现出较低的幼稚 CD4 T 细胞产生(CD45RACD31 细胞),较高的自发体外 CD4 T 细胞死亡和较高的可溶性 CD14 血浆水平。多变量分析显示,CD4 T 细胞的活化和死亡以及 CD4 T 细胞计数的最低值是免疫恢复不良的唯一预测因素。此外,发现 CD4 T 细胞活化或死亡与胸腺输出和细菌易位之间的低相关性表明,其他因素调节细胞的活化和死亡,进而调节 CD4 T 细胞的恢复。
HAART 期间的 CD4 T 细胞再群体取决于 CD4 T 细胞的激活和死亡。因此,应考虑采用旨在减少这些参数的策略来治疗不一致的患者。